Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics / Hsien Yuan Lane en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 4 (Agosto) . - pp. 353-358 Título : Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics Tipo de documento: texto impreso Autores: Hsien Yuan Lane, Autor ; Yue Cune Chang, Autor ; Chi Chiang Chiu, Autor Fecha de publicación: 2023 Artículo en la página: pp. 353-358 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Hospitalización, Pacientes, Risperidona, Esquizofrenia Resumen: Response predictors of risperidone or other newer atypical antipsychotics for schizophrenia treatment remain unclear. This study aimed to investigate the influence of patient demographics on risperidone efficacy for schizophrenia. One hundred twenty-one newly hospitalized patients who had schizophrenia with acute exacerbation entered this prospective, 6-week risperidone trial. Link: ./index.php?lvl=notice_display&id=31050 [artículo] Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics [texto impreso] / Hsien Yuan Lane, Autor ; Yue Cune Chang, Autor ; Chi Chiang Chiu, Autor . - 2023 . - pp. 353-358. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 4 (Agosto) . - pp. 353-358 Palabras clave: Antipsicóticos, Hospitalización, Pacientes, Risperidona, Esquizofrenia Resumen: Response predictors of risperidone or other newer atypical antipsychotics for schizophrenia treatment remain unclear. This study aimed to investigate the influence of patient demographics on risperidone efficacy for schizophrenia. One hundred twenty-one newly hospitalized patients who had schizophrenia with acute exacerbation entered this prospective, 6-week risperidone trial. Link: ./index.php?lvl=notice_display&id=31050

Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects / Hsien Yuan Lane en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 4-10 Título : Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects Tipo de documento: texto impreso Autores: Hsien Yuan Lane, Autor ; Yue Cune Chang, Autor ; Muh-Hwan Su, Autor Fecha de publicación: 2023 Artículo en la página: pp. 4-10 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Enfermedad de Alzheimer, Antipsicóticos, Demencia Vascular, Haloperidol, Pruebas neuropsicológicas, Agitación psicomotora, Risperidona, Trastornos de la conducta social Resumen: For agitated dementia showing insufficient response to conventional antipsychotics, the feasibility of transition to atypical agents remains unknown. Sixty-two Chinese inpatients with dementia and disruptive behaviors were recruited into an 8-week screening trial of haloperidol. Thirty-five (56%) of them responded insufficiently. Link: ./index.php?lvl=notice_display&id=31087 [artículo] Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects [texto impreso] / Hsien Yuan Lane, Autor ; Yue Cune Chang, Autor ; Muh-Hwan Su, Autor . - 2023 . - pp. 4-10. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 4-10 Palabras clave: Enfermedad de Alzheimer, Antipsicóticos, Demencia Vascular, Haloperidol, Pruebas neuropsicológicas, Agitación psicomotora, Risperidona, Trastornos de la conducta social Resumen: For agitated dementia showing insufficient response to conventional antipsychotics, the feasibility of transition to atypical agents remains unknown. Sixty-two Chinese inpatients with dementia and disruptive behaviors were recruited into an 8-week screening trial of haloperidol. Thirty-five (56%) of them responded insufficiently. Link: ./index.php?lvl=notice_display&id=31087

---

1 (1 - 2 / 2)